Insys opioid lawsuit settlement
Insys Settles Illinois Opioid Lawsuit for $4.5 Million
August 7, 2017
Drugmaker Insys will pay $4.5 million to settle allegations of deceptively marketing its fentanyl-based cancer medication in a lawsuit brought by Illinois Attorney General Lisa Madigan.
The Arizona pharmaceutical manufacturer has been in a great deal of legal trouble lately, most of it stemming from several of its former officers confessing to having participated in a scheme to bribe doctors to promote its powerful opioid medication Subsys. Six former execs of the company have pleaded guilty, but former CEO Michael Babich and others have pleaded not guilty.
Subsys was the focus of the Illinois suit, as well, in which Madigan alleged that Insys had marketed the drug for purposes for which it had not received approval from the U.S. Food and Drug Administration (FDA).
Just this week, Insys, still an extant company, released a new drug called Syndros. The active ingredient in Syndros is THC, the active ingredient in cannabis; Insys intends the drug to be used for the treatment of chemotherapy-induced nausea.
Opioid addiction claims the lives of some 30,000 Americans every year.
If you or a loved one has suffered the horrors of opioid addiction, contact TheLawFirm.com. We know how to help you.
Click For A Free Consultation!
VA urged to address risks of opioids for veterans
More states added to lawsuit against opioid makers
Drugstores try to block cherokee opioid lawsuit
Insys settles Illinois opioid lawsuit
Insys Blue Cross and Blue Shield lawsuit
Fentanyl likely cause of boys death
FDA urged to block opioid suppliers
Opioid Atty Gen
FDA urged to remove opioids from market
FDA urges Opana to be pulled from the shelves
Oxycontin secret marketing
FDA approved drugs
FDA denies use of blue dye in opioids
FDA faults Canadian drugmaker for opioid abuse
Opioid lawsuit settlement
Opioids causing National epidemic
Opioid privileges revoked
TheLawFirm.com’s award winning lawyers have been featured in over 50 radio and television interviews including:
Real lawyers, real results!
no recovery, no fee!